期刊： KIDNEY MEDICINE, 2023; 5 (1)
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is the second most common monoclonal gammopathy of renal significanc......
期刊： KIDNEY MEDICINE, 2023; 5 (4)
Rationale & Objective: Widespread delivery of high-quality care for acute kidney injury (AKI) survivors after hospital discharge requires a multid......
期刊： KIDNEY MEDICINE, 2023; 5 (6)
Rationale & Objective: Continuous kidney replacement therapy (CKRT) is the predominant form of acute kidney replacement therapy used for criticall......
期刊： KIDNEY MEDICINE, 2023; 5 (9)
Rationale & Objective: Chronic kidney disease (CKD) is a major cause of morbidity and mortality. To date, there are no widely used machine-learnin......
期刊： KIDNEY MEDICINE, 2023; 5 (11)
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A ......
期刊： KIDNEY MEDICINE, 2023; 5 (2)
Rationale & Objective: There has been an increasing demand for the expertise provided by a renal genetics clinic. Such programs are limited in the......
期刊： KIDNEY MEDICINE, 2023; 5 (5)
Rationale & Objective: Dietary factors may impact inflammation and interferon production, which could influence phenotypic expression of Apolipo-p......
期刊： KIDNEY MEDICINE, 2023; 5 (5)
Rationale and Objective: The 'PEER-HD' multi-center study tests the effectiveness of peer mentorship to reduce hospitalizations in patients receiving ......
期刊： KIDNEY MEDICINE, 2023; 5 (12)
Heart failure with preserved ejection fraction (HFpEF) is a heterogenous syndrome with varying phenotypic expression. The phenotype chronic kidney dis......
期刊： KIDNEY MEDICINE, 2023; 5 (3)
Rationale & Objective: Estimation of glomerular filtration rate (eGFR) and staging of chronic kidney disease (CKD) are essential to guide manageme......
期刊： KIDNEY MEDICINE, 2023; 5 (8)
Rationale & Objective: Greater prognostic under-standing is associated with higher quality care at the end of life. We undertook a scoping review ......
